Crystal methamphetamine and initiation of injection drug use among street-involved youth in a Canadian setting

CMAJ. Canadian Medical Association Journal

Volumn 185, Issue 18, 2013, Pages 1569-1575

  Werb, Dan ^a   Kerr, Thomas ^a   Buxton, Jane ^a,b   Shoveller, Jeannie ^a   Richardson, Chris ^a   Montaner, Julio ^a   Wood, Evan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; JUVENILE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL METHOD; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; YOUNG ADULT;

EID: 84890301078     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.130295     Document Type: Article

References (40)

1. Fuller CM, Vlahov D, Ompad DC, et al. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend 2002;66:189-98.
2. AIDS epidemic update: November 2009. Geneva (Switzerland): Joint United Nations Programme on HIV/AIDS; 2009.
3. Backmund M, Reimer J, Meyer K, et al. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment. Clin Infect Dis 2005;40:S330-5.
4. Darke S, Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health 2003;80:189-200.
5. Brugal MT, Barrio G, Fuente LDL, et al. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002;97:319-27.
6. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T- lymphotropic viruses. Am J Public Health 1996;86:655-61.
7. Tagliaro F, Battisti ZD, Smith FP, et al. Death from heroin overdose: findings from hair analysis. Lancet 1998;351:1923-5.
8. van Haastrecht HJA, Van Ameijden EJC, Van Den Hoek JAR, et al. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol 1996;143:380-91.
9. Vlahov D, Fuller CM, Ompad DC, et al. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health 2004;81:14-9.
10. Roy E, Haley N, Leclerc P, et al. Drug injection among street youths in Montréal: predictors of initiation. J Urban Health 2003; 80:92-105.
11. Fuller CM, Vlahov D, Arria AM, et al. Factors associated with adolescent initiation of injection drug use. Public Health Rep 2001;116(Suppl 1):136-45.
12. Wood E, Stolz JA, Montaner JS, et al. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J 2006;3:1.
13. World drug report 2012. Vienna (Austria): United Nations Office on Drugs and Crime; 2012.
14. Drug situation in Vancouver. Vancouver (BC): BC Centre for Excellence in HIV/AIDS, Urban Health Research Initiative; 2013.
15. Colfax G, Santos GM, Chu P, et al. Amphetamine-group substances and HIV. Lancet 2010;376:458-74.
16. Boivin JF, Roy E, Haley N, et al. The health of street youth. Can J Public Health 2005;96:432-7.
17. DeMatteo D, Major C, Block B, et al. Toronto street youth and HIV/AIDS: prevalence, demographics, and risks. J Adolesc Health 1999;25:358-66.
18. Elliott AS. Meeting the health care needs of street-involved youth. Paediatr Child Health 2013;18:317-21.
19. Fuller CM, Borrell LN, Latkin CA, et al. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health 2005;95:689-95.
20. Sherman SG, Fuller CM, Shah N, et al. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J Psychoactive Drugs 2005;37:437-43.
21. Rothman K, Greenland S. Modern epidemiology. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
22. Fast D, Small W, Wood E, et al. Coming 'down here': young people's reflections on becoming entrenched in a local drug scene. Soc Sci Med 2009;69:1204-10.
23. Werb D, Kerr T, Fast D, et al. Drug-related risks among street youth in two neighborhoods in a Canadian setting. Health Place 2010; 16:1061-7.
24. Fast D, Shoveller J, Shannon K, et al. Safety and danger in downtown Vancouver: understandings of place among young people entrenched in an urban drug scene. Health Place 2010;16:51-60.
25. Trenz RC, Harrell P, Scherer M, et al. A model of school problems, academic failure, alcohol initiation, and the relationship to adult heroin injection. Subst Use Misuse 2012;47:1159-71.
26. Crofts N, Louie R, Rosenthal D, et al. The first hit: circumstances surrounding initiation into injecting. Addiction 1996;91:1187-96.
27. Young AM, Havens JR. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction 2012;107:587-96.
28. Neaigus A, Gyarmathy VA, Miller M, et al. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr (1999) 2006;41:493-503.
29. Buster MCA, Witteveen E, Prins M, et al. Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study. Eur Addict Res 2009;15:179-87.
30. Epi-update: crystal methamphetamine use among Canadian street-involved youth (1999-2005). Ottawa (ON): Public Health Agency of Canada; 2009.
31. Cretzmeyer M, Sarrazin MV, Huber DL, et al. Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat 2003;24:267-77.
32. Marshall BDL, Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 2010;105:991-1002.
33. Ouellet LJ, Bailey SL. Drug injection initiation and hepatitis C virus (HCV) infection: an assessment of opportunities for intervention [abstract]. National Viral Hepatitis Prevention Conference; 2005 Dec. 5-9; Washington (DC).
34. Against the odds: a profile of marginalized and street-involved youth in BC. Vancouver (BC): The McCreary Centre Society; 2007.
35. Street youth in Canada. Ottawa (ON): Public Health Agency of Canada; 2006.
36. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev 2002;14:367-78.
37. Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, et al. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry 2012;53:304-12.
38. Szobot CM, Rohde LA, Bukstein O, et al. Is attention-deficit/ hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study. Addiction 2007;102:1122-30.
39. Volkow ND, Li TK. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci 2004;5:963-70.
40. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, et al. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet 2010;376:551-63.